Drug class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
15 drugs the FDA files under Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- Bictegravir, emtricitabine and tenofovir · 2 strengths and formsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Emtricitabine · 2 strengths and formsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor$360.75Cost Plus Drugs
- Emtricitabine and tenofovir · 5 strengths and formsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor$234.25Cost Plus Drugs
- Emtricitabine, rilpivirine and tenofovir · 3 strengths and formsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Zidovudine · 3 strengths and formsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor$57.93Cost Plus Drugs
Cheapest option we hold for the usual fill, fees included, checked November 4, 2026. Open a medicine for every option and the date on each one.